US Drug Recall Register
Class I · High risk Terminated Initiated Sep 5, 2017 (9 years ago)

Activase

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials.

What was recalled

Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vial of sterile water for Injection USP and one transfer device. Manufactured by: Genentech, Inc. 1 DNA Way, South San Francisco, CA 84080-4990. NDC: 50242-0085-27

Recalling firm
Genentech, Inc.
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1175-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Alteplase recalls

See all
Class II · Moderate risk Terminated

Cathflo activase

Reason Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.

Genentech, Inc. NDC 50242-041-64 D-0509-2024
Class II · Moderate risk Terminated

cathflo activase

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 50242-041-64 D-0476-2021
Class II · Moderate risk Terminated

Alteplase

Reason Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1453-2012